| 1. |
|
|
| 2. |
- J.G., Cohen, et al.
(författare)
-
Abundances In Very Metal-Poor Dwarf Stars
- 2004
-
Ingår i: Astrophysical Journal. - 0004-637X. ; 603:2, s. 1107-1135
-
Tidskriftsartikel (populärvet., debatt m.m.)abstract
- We discuss the detailed composition of 28 extremely metal-poor (EMP) dwarfs, 22 of which are from the Hamburg/ESO Survey (HES), based on Keck echelle spectra. Our sample has a median [Fe/H] of -2.7 dex, extends to -3.5 dex, and is somewhat less metal-poor than was expected from [Fe/H](HK, HES) determined from low-resolution spectra. Our analysis supports the existence of a sharp decline in the distribution of halo stars with metallicity below [Fe/H]=-3.0 dex. So far no additional turnoff stars with [Fe/H]<-3.5 have been identified in our follow-up efforts. For the best-observed elements between Mg and Ni, we find that the abundance ratios appear to have reached a plateau, i.e., [X/Fe] is approximately constant as a function of [Fe/H], except for Cr, Mn, and Co, which show trends of abundance ratios varying with [Fe/H]. These abundance ratios at low metallicity correspond approximately to the yield expected from Type II supernovae (SNe) with a narrow range in mass and explosion parameters; high-mass Type II SN progenitors are required. The dispersion of [X/Fe] about this plateau level is surprisingly small and is still dominated by measurement errors rather than intrinsic scatter. These results place strong constraints on the characteristics of the contributing SNe. The dispersion in neutron-capture elements and the abundance trends for Cr, Mn, and Co are consistent with previous studies of evolved EMP stars. We find halo-like enhancements for the α-elements Mg, Ca, and Ti, but solar Si/Fe ratios for these dwarfs. This contrasts with studies of EMP giant stars, which show Si enhancements similar to other α-elements. Sc/Fe is another case where the results from EMP dwarfs and from EMP giants disagree; our Sc/Fe ratios are enhanced compared to the solar value by ~0.2 dex. Although this conflicts with the solar Sc/Fe values seen in EMP giants, we note that α-like Sc/Fe ratios have been claimed for dwarfs at higher metallicity. Two dwarfs in the sample are carbon stars, while two others have significant C enhancements, all with 12C/13C ~7 and with C/N between 10 and 150. Three of these C-rich stars have large enhancements of the heavy neutron capture elements, including lead, which implies a strong s-process contribution, presumably from binary mass transfer; the fourth shows no excess of Sr or Ba.
|
|
| 3. |
- McClune, Brian L., et al.
(författare)
-
Allotransplantation for Patients Age >= 40 Years with Non-Hodgkin Lymphoma : Encouraging Progression-Free Survival
- 2014
-
Ingår i: Biology of blood and marrow transplantation. - : Elsevier BV. - 1083-8791 .- 1523-6536. ; 20:7, s. 960-968
-
Tidskriftsartikel (refereegranskat)abstract
- Non-Hodgkin lymphoma (NHL) disproportionately affects older patients, who do not often undergo allogeneic hematopoietic cell transplantation (HCT). We analyzed Center for International Blood and Marrow Transplant Research data on 1248 patients age >= 40 years receiving reduced-intensity conditioning (RIC) or nonmyeloablative (NMA) conditioning HCT for aggressive (n = 668) or indolent (n = 580) NHL Aggressive lymphoma was more frequent in the oldest cohort 49% for age 40 to 54 versus 57% for age 55 to 64 versus 67% for age >= 65; P = .0008). Fewer patients aged >= 65 had previous autografting (26% versus 24% versus 9%; P = .002). Rates of relapse, acute and chronic GVHD, and nonrelapse mortality (NRM) at 1 year post-HCT were similar in the 3 age cohorts (22% [95% confidence interval (CI), 19% to 26%] for age 40 to 54, 27% [95% CI, 23% to 31%] for age 55 to 64, and 34% [95% CI, 24% to 44%] for age >= 65. Progression-free survival (PFS) and overall survival (OS) at 3 years was slightly lower in the older cohorts (OS: 54% [95% CI, 50% to 58%] for age 40 to 54; 40% [95% CI, 36% to 44%] for age 55 to 64, and 39% [95% CI, 28% to 50%] for age >= 65; P < .0001). Multivariate analysis revealed no significant effect of age on the incidence of acute or chronic GVHD or relapse. Age >= 55 years, Karnofsky Performance Status <80, and HLA mismatch adversely affected NRM, PFS, and OS. Disease status at HCT, but not histological subtype, was associated with worse NRM, relapse, PFS, and OS. Even for patients age >= 55 years, OS still approached 40% at 3 years, suggesting that HCT affects long-term remission and remains underused in qualified older patients with NHL.
|
|
| 4. |
|
|
